Medscape

Adaptive Cardiac Resynchronization Therapy Device: A Simulation Report

The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...
MassDevice

Medtronic wins expanded FDA approval for OmniaSecure for conduction pacing

Medtronic (NYSE: MDT) announced today that it received FDA approval for an expanded indication for its OmniaSecure defibrillation lead.
Yahoo

New device gives heart failure patients more options to stay in rhythm

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Robert Canby, a cardiac electrophysiologist, describes an FDA-approved novel lead-less system that provides cardiac ...
Medical Device and Diagnostic Industry (MD+DI)

Medtronic’s Tiny Defibrillation Lead Packs a Big Punch

Medtronic snagged FDA approval for an expanded indication for its OmniaSecure defibrillation lead. Check out why this tiny ...
Healio

SOLVE-CRT: Leadless pacemaker can deliver CRT to people not suited for traditional systems

Please provide your email address to receive an email when new articles are posted on . A leadless pacemaker can deliver cardiac resynchronization therapy to patients who cannot have conventional CRT ...
Yahoo Finance

BIOTRONIK Expands Cardiac Rhythm Care by Launching World's First CRT-D Systems Approved for Conduction System Pacing

BERLIN, Feb. 12, 2026 /PRNewswire/ -- BIOTRONIK today announced the launch of the new Acticor Sky and Rivacor Sky device family featuring the world's first CE-approved left bundle branch area pacing ...
MedPage Today

Hybrid Device for Heart Failure Shows Early Promise

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...
Healio

Novel ICD platform may benefit patients with HFrEF at risk for sudden cardiac death

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
TCTMD

Societies Update Appropriate Use Criteria for Cardiac Implantable Devices

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...
MedPage Today

Deciding on Implantable Cardiac Devices for Cardiomyopathy

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Nature

Benefits of cardiac resynchronization therapy

Results from the Cardiac Resynchronization—Heart Failure (CARE-HF) study support the use of implantable cardiac-resynchronization devices in patients with heart failure due to left-ventricular ...